Atrium Therapeutics, Inc.
← Back to RNA Overview

Atrium Therapeutics, Inc. (RNA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.17

Financial Fundamentals

RNAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2025-09-30
2025-12-31-2.17

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.